Surgical and Multimodality Approaches to Liver Metastases

  • P. M. Schlag
  • M. Hünerbein
  • P. Hohenberger
Part of the Current Topics in Microbiology and Immunology book series (CT MICROBIOLOGY, volume 213/3)


Although liver metastases may provide the first evidence of cancer progression, they almost always indicate general dissemination of malignancy. Treatment options for hepatic metastases include surgical resection, administration of regional chemotherapy, systemic chemotherapy, radiotherapy, and various innovative strategies to achieve specific drug targeting. In spite of all advances, surgery is currently the only therapy that prolongs survival or even provides the chance of cure. Technical standards constitute no longer a limiting factor in the use of hepatic resection for malignant disease. Although hepatic resection remains a major procedure, current mortality rates of 0%–6% justify widespread use of this type of surgery (Foster and Lundy 1981; Gayowski et al. 1994). Consequently, it is now even more important to establish accurate guidelines defining the indications of hepatic resection for malignant disease.


Gastric Cancer Liver Metastasis Liver Resection Hepatic Resection Hepatic Metastasis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. Adam YG, Efron G (1989) Trends and controversies in the management of carcinoma of the stomach. Surg Gynecol Obstet 169: 371–385PubMedGoogle Scholar
  2. Adson MA, vanHeerden JA, Adson MH, Wagner JS, Ilstrup DM (1984) Resection of hepatic metastases from colorectal cancer. Arch Surg 119: 647–651PubMedGoogle Scholar
  3. Al Jarallah MA, Behbehani AE, el Nass SA, Temim L, Ebraheem AK, Ali MA, Szymendera JJ (1993) Serum CA-15.3 and CEA patterns in postsurgical follow-up, and in monitoring clinical course of metastatic cancer in patients with breast carcinoma. Eur J Surg Oncol 19: 74–79PubMedGoogle Scholar
  4. Asbum HJ, Tsao Jl, Hughes KS (1994) Resection of hepatic metastases from colorectal carcinoma. The registry data. Cancer Tract Res 69: 33–41Google Scholar
  5. August DA, Sugarbaker PH, Ottow RT, Gianola FJ, Schneider PD (1985) Hepatic resection of colorectal metastases. Influence of clinical factors and adjuvant interaperitoneal 5-fluorouracil via Tenckhoff catheter on survival. Ann Surg 201: 210–218PubMedCrossRefGoogle Scholar
  6. Baba H, Okuyama T, Hiroyuki O, Anai H, Korenaga D, Maehara Y, Akazawa K, Sugimachi K (1992) Prognostic factors for noncurative gastric cancer: univariate and multivariate analyses. J Surg Oncol 51:104–108PubMedCrossRefGoogle Scholar
  7. Ballantyne GH, Quin J (1993) Surgical treatment of liver metastases in patients with colorectal cancer. Cancer 71: 4252–4266PubMedCrossRefGoogle Scholar
  8. Barone R, Goldfarb P, Sahleh F, Kogler J, Shiftan T, Weiss R (1990) Liver resection and adjuvant intraarterial FUDR therapy for the treatment of metastatic colon carcinoma. Proc Am Soc Clin Oncol 9: 443Google Scholar
  9. Bines SD, England G, Deziel DJ, Witt TR, Doolas A, Roseman DL (1993) Synchronous, metachronous, and multiple hepatic resections of liver tumors originating from primary cjastric tumors. Surgery 114: 799–805PubMedGoogle Scholar
  10. Cobourn CS, Makowka L, Langer B, Taylor BR, Falk RE (1987) Examination of patient selection and outcome for hepatic resection for metastatic disease. Surg Gynecol Obstet 165: 239–246PubMedGoogle Scholar
  11. Collier BD, Foley WD (1993) Current imaging strategies for colorectal cancer. J Nucl Med 34: 537–540PubMedGoogle Scholar
  12. Curley SA, Roh MS, Chase IL, Hohn DC (1993) Adjuvant hepatic infusion chemotherapy after curative resection of colorectal liver metastases. Am J Surg 166: 746–748CrossRefGoogle Scholar
  13. Donato N, Dario C, Giovanni S, Virgilio B, Paolo DP, Roberto L, Gianfranco P, Mario L, Daniela P, Angelo T et al. (1994) Retrospective study on adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Eur J Surg Oncol 20: 454–460PubMedGoogle Scholar
  14. Elias D, Lasser P, Spielmann M, May Levin F, el Malt O, Thomas H, Mouriess H (1991) Surgical and chemotherapeutic treatment of hepatic metastases from carcinoma of the breast. Surg Gynecol Obstet 172: 461–464PubMedGoogle Scholar
  15. Elias D, Lasser P, Hoang JM, Lecler J, Debaene B, Bognel C, Spencer A, Rougier P (1993) Repeat hepatectomy for cancer. Br J Surg 80: 1557–1562PubMedCrossRefGoogle Scholar
  16. Ferrucci JT (1990) Liver tumor imaging: current concepts. AJR 155: 473–483PubMedGoogle Scholar
  17. Fortner JG, Silva JS, Cox EB, Maclean JB (1984) Multivariate analysis of a personal series of 247 consecutive patients with liver metastases from colorectal cancer. Ann Surg 199: 306–316PubMedCrossRefGoogle Scholar
  18. Foster JH (1978) Survival after liver resection for secondary tumors. Am J Surg 135: 389–394PubMedCrossRefGoogle Scholar
  19. Foster JH (1990) Surgical treatment of metastatic liver tumors. Hepatogastroenterology 37: 182–187PubMedGoogle Scholar
  20. Foster JH, Lundy J (1981) Pathology of liver metastases. Curr Probl Surg 18: 157–160PubMedCrossRefGoogle Scholar
  21. Fowler WC, Hoffman JP, Eisenberg BL (1993) Redo hepatic resection for metastatic colorectal carcinoma. World J Surg 17: 658–661PubMedCrossRefGoogle Scholar
  22. Freeny PC, Marks WM (1986) Hepatic hemangioma: dynamic bolus CT. AJR 147: 713–719Google Scholar
  23. Funovics JM, Wenzel E, Függer R, Schemper M (1986) Leberresektionen wegen hämatogener oder infiltrierender Metastasen. Wien Klin Wochenschr 98: 813–820PubMedGoogle Scholar
  24. Gayowski TJ, Iwatsuki S, Madaraga JR, Selby R, Todo S, Irish W, Starzl TE (1994) Experience in hepatic resection for metastatic colorectal cancer: analysis of clinical and pathologic risk factors. Surgery 116:703–711PubMedGoogle Scholar
  25. Geraghty JG, Coveney EC, Sherry F, O’Higgins NJ, Duffy MJ (1992). CA 15–3 in patients with locoregional and metastatic breast carcinoma. Cancer 70: 2831–2834PubMedCrossRefGoogle Scholar
  26. Gerard A, Buyse M, Pector JC, Bleiberg H, Arnaud JP, Willoms G, Delvaux G, Nitti D, Depadt G et al. (1991) Hepatic artery ligation with and without portal infusion of 5-FU. A randomized study in patients with unresectable liver metastases from colorectal carcinoma. The E.O.R.T.C. Gastrointestinal Cancer Cooperative Group (G.I. Group). Eur J Surg Oncol 17: 289–294PubMedGoogle Scholar
  27. Goslin R, Steele G, Zamscheck N (1982) Factors influencing survival in patients with hepatic metastases from adenocarcinoma of the colon and rectum. Dis Colon Rectum 25: 249–754CrossRefGoogle Scholar
  28. Habu H, Saito N, Sato Y, Takerchita K, Sunagawa M, Endo M (1990) Results of surgery in patients with gastric cancer extending to the adjacent organs. Hepatogastroenterology 37: 417–420PubMedGoogle Scholar
  29. Hasemann MK, Brown DW, Keeling CA, Reed NL (1992). Radioimmunodetection of occult carcino-embryonic antigen producing cancer. J Nucl Med 33: 1750–1756Google Scholar
  30. Hohenberger P, Schlag PM, Gerneth T, Herfarth C (1994) Pre- and postoperative carcinoem-bryonic antigen determinations in hepatic resection for colorectal metastases. Predictive value and implications for adjuvant treatment based on multivariate analysis. Ann Surg 219: 135–143PubMedCrossRefGoogle Scholar
  31. Hölting T, Schlag P, Georgi P (1990). Current status of immunoscintigraphy in colorectal cancer-results of 5 years clinical experience. Eur J Surg Oncol 16: 312–318PubMedGoogle Scholar
  32. Hughes KS, Simon RM, Songhorabodi S (1988) Resection of the liver for colorectal carcinoma metastases: a multiinstitutional study of indications for resection. Surgery 103: 278–288.Google Scholar
  33. Hünerbein M, Rau B, Schlag PM (1994) Laparoscopy and laparoscopic ultrasound for staging of gastrointestinal tumors. Eur J Surg Oncol 21: 50–55Google Scholar
  34. Hunt TM, Flowerdew ADS, Birch SJ, Williams JD, Mulle MA, Taylor I (1990) Prospective randomized controlled trial of hepatic arterial embolization of infusion chemotherapy with 5-fluorouracil and degradable starch microspheres for colorectal liver metastastases. Br J Surg 77: 779–783PubMedCrossRefGoogle Scholar
  35. Imdahl A, Bräutigam P, Hauenstein KH, Eggstein S, Waninger J, Farthmann EH (1994) The value of CEA immunoscintigraphy for diagnosis of colorectal cancer and its metastases: results of a prospective study. Zentralbl Chir 119: 17–22PubMedGoogle Scholar
  36. Iwatsuki S, Sheahan DG, Starzl TE (1989) The changing face of hepatic resection. Curr Probl Surg 26: 283–379CrossRefGoogle Scholar
  37. Kemeny N, Conti J, Seiter K (1992) A phase I trial intrahepatic fluorodesoxyuridine (FUDR) and systemic 5-fluorouracil (5-FU) + leucovorin in metastatic colorectal cancer: a useful adjuvant program after resection of colorectal metastases? Proc Am Soc Clin Oncol 11: 194Google Scholar
  38. Koga, S, Kawaguchi H, Kishimoto H (1980) Therapeutic significance of non-curative gastrectomy for gastric cancer with liver metastasis. Am J Surg 140: 356–359PubMedCrossRefGoogle Scholar
  39. Koneru, B, Bassavilla A, Bowman J (1988) Liver transplantation for malignant tumors. Gastroenterol Clin North Am 17: 177–182PubMedGoogle Scholar
  40. Korenaga, D, Okamura T, Baba H, Saito A, Sugimachi K (1988) Results of resection of gastric cancer extending to adjacent organs. Br J Surg 75: 12–15PubMedCrossRefGoogle Scholar
  41. Kortz WJ, Myers WC, Hanks JB, Schirmer B, Jones S (1984) Hepatic resection for metastatic cancer. Ann Surg 199: 182–184PubMedCrossRefGoogle Scholar
  42. Lahr CJ, Scong SJ, Cloud G (1983) A multifactorial analysis of prognostic factors in patients with liver metastases from colorectal carcinoma. J Clin Oncol 1: 720–726PubMedGoogle Scholar
  43. Lorenz M, Hottenroth C, Maier P, Reimann M, Inglis R, Encke A (1992) Continuous regional treatment with fluoropyrimidines for metastases from colorectal carcinomas: influence of modulation with leucovorin. Semin Oncol 19: 163–170PubMedGoogle Scholar
  44. Lorenz M, Stabe-Schler E, Rossion I, Koch R, Gag C, Encke A (1995) Ergebnisse der Resektion und adjuvanten Therapie von Lebermetastasen. Zentralbl Chir 120: 279–289Google Scholar
  45. Lucarotti ME, Rothnie ND, Kelly SB, Hershman MJ, Johanssen C, Nilsson O, Lindholm L, Wood CB, Williamson RC, Habib NA (1991) Clinical evaluation of tumour marker combinations in the differential diagnosis of benign and malignant liver disease. HPB Surg 5: 23–28PubMedCrossRefGoogle Scholar
  46. Martin JK Jr, O’Connell MJ, Wieand HS, Fitzgibbons RJ Jr, Mailliard JA, Nagorney DM, Tschetter LK, Krook JE (1990). Intra-arterial floxuridine vs systemic fluorouracil for hepatic metastases from colorectal cancer. A randomized trial. Arch Surg 125: 1022–1027PubMedGoogle Scholar
  47. Mavligit G, Charnsangavej C, Talpaz M, Gutterman J, Wallace S (1988) Splenic versus hepatic artery infusion of recombinant interleukin-2 for patients with liver metastases. Proc Am Soc Clin Oncol 7: 107Google Scholar
  48. McFarland EG, Mayo Smith WW, Saini S, Hahn PF, Goldberg MA, Lee MJ (1994). Hepatic hemangiomas and malignant tumors: improved differentiation with heavily T2-weighted conventional spin-echo MR imaging. Radiology 193: 43–47PubMedGoogle Scholar
  49. Meirion-Thomas J, Redding WH, Coombes RC (1978) Failure to detect intraabdominal metastases from breast cancer: a case for staging laparotomy. Br J Med 2: 157–159CrossRefGoogle Scholar
  50. Mitchell DG, Saini S, Weinreb J, De Lange EE, Runge VM, Kuhlman JE, Parisky Y, Johnson CD, Brown JJ, Schnall M et al. (1994) Hepatic metastases and cavernous hemangiomas: distinction with standard- and triple-dose gadoteridol-enhanced MR imaging. Radiology 193: 49–57PubMedGoogle Scholar
  51. Moriya Y, Sugihara K, Hojo K, Makuuchi M (1991) Adjuvant hepatic intra-arterial chemotherapy after potentially curative hepatectomy for liver metastases from colorectal cancer. Eur J Surg Oncol 17:519PubMedGoogle Scholar
  52. Morrow CE, Grage TB, Sutherland DER, Najarían JS (1982) Hepatic resection for secondary neoplasms. Surgery 92: 610–614PubMedGoogle Scholar
  53. NIH (1990) NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA 264 (11): 1444–1450CrossRefGoogle Scholar
  54. Nordlinger B, Vaillant, JC, Guiguet M, Balladur P, Paris F, Bachellier P, Jaeck D. (1994) Survival benefit of repeat liver resections for recurrent colorectal metastases: 143 cases. Association Française de Chirurgie. J Clin Oncol 12: 1491–1496.PubMedGoogle Scholar
  55. O’Connell, MJ, Adson, MA, Schutt, AJ, Rubin, J, Moertel, CG, Ilstrup, DM (1985) Clinical trial of adjuvant chemotherapy after surgical resection of colorectal cancer metastatic to the liver. Mavo Clin Proc 60: 517–520Google Scholar
  56. Okuyama K, Isono K, Juan IK (1985) Evaluation of treatment for gastric cancer with liver metastases. Cancer 55: 2498–2505PubMedCrossRefGoogle Scholar
  57. Ramming KP, Sparks FC, Eilber F, Morton D (1977) Management of hepatic metastases. Semin Oncol 4: 71–80PubMedGoogle Scholar
  58. Ringe B, Bephstein WO, Raab R, Meyer HJ, Pichlmayr R (1990) Leberresektionen bei 157 Patienten mit colorektalen Metastasen. Chirurg 61: 272–279PubMedGoogle Scholar
  59. Rougier P, Hay JM, Olliver JM (1990) A controlled multicentric trial of intrahepatic chemotherapy (IHC) vs standard palliative treatment for colorectal liver metastases. Proc Am Soc Clin Oncol 9: 104Google Scholar
  60. Scheele J, Stangl R, Altendorf Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77(11): 1241–1246.PubMedCrossRefGoogle Scholar
  61. Schlag P, Manasterski M, Gerneth T, Hohenberger P, Dueck M, Herfarth C, Liebrich W, Schirrmacher V (1992) Active specific immunotherapy with Newcastle disease virus modified autologous cancer: first evaluation of clinical response of a phase II trial. Cancer Immunol Immunother 35: 325–329PubMedCrossRefGoogle Scholar
  62. Semelka RC, Shoenut JP, Ascher SM, Kroeker MA, Greenberg HM, Yafta CS, Micflikier AB (1994) Solitary hepatic metastasis: comparison of dynamic contrast-enhanced CT and MR imaging withfat-suppressed T2-weighted breath-hold T1-weighted FLASH, and dynamic gadolinium-enhanced FLASH sequences. J Magn Reson Imaging 4: 319–323PubMedCrossRefGoogle Scholar
  63. Soyer P, Bluemke DA, Hruban RH, Sitzmann JV, Fishman EK (1994) Hepatic metastases from colorectal cancer: detection and false-positive findings with helical CT during arterial portography. Radiology 193: 71–74PubMedGoogle Scholar
  64. Steele G Jr, Bleday R, Mayer RJ, Lindblad A, Petrelli N, Weaver D (1991) A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584. J Clin Oncol 9: 1105–1112PubMedGoogle Scholar
  65. Stehlin JS, Delpoly PD, Greef PJ et al. (1988) Twenty years experience with infusion and resection in 414 patients. Ann Surg 208: 23–25PubMedCrossRefGoogle Scholar
  66. Stimpson RE, Pellegrini CA, Way IW (1987) Factors affecting the morbidity of elective liver resection. Am J Surg 153: 189–196PubMedCrossRefGoogle Scholar
  67. Sturm J, Raute M, Trede M (1991) Operationsindikation bei Lebermetastasen nicht kolorektaler Karzinome. In: Herfarth C, Schlag PU (eds) Neue Entwicklungen in der Therapie von Lebertumoren, Springer, Berlin Heidelberg New York, pp 337–344CrossRefGoogle Scholar
  68. Swanson DA, Johnson DE, von Eschenbach A, Chuang VP, Wallace S (1983) Angioinfarction plus nephrectomy for metastatic renal cell carcinoma - an update. J Urol 130: 4498–4451Google Scholar
  69. Tabuchi Y, Boku S, Kato M, Takita Y, Kawaguch K (1977) Clinicopathological and prognostic studies of gastric cancer macroscopically invading neighboring organs. Jpn J Cancer Clin 22: 964–973Google Scholar
  70. Thompson H, Tompkins R, Longmire WP (1983) Major hepatic resection. Ann Surg 197: 375–388PubMedCrossRefGoogle Scholar
  71. Tomas de la Vega JE, Donahue EJ, Doolas A (1984) A ten year experience with hepatic resection. Surg Gynecol Obstet 159: 223–228Google Scholar
  72. Tsujitani S, Watanabe A, Kakeji Y, Machara Y, Machara Y, Tomoda H, Furusawa M (1991) Hepatic recurrence not prevented with low-dosage long-term intraportal 5-FU infusion after resection of colorectal liver metastasis. Eur J Surg Oncol 17: 526–529PubMedGoogle Scholar
  73. Vogt P, Raab R, Ringe B, Pichlmayr R (1991) Resection of synchronous liver metastases from colorectal cancer. World J Surg 15: 62–67PubMedCrossRefGoogle Scholar
  74. Wagner JS, Adson MA, van Heerden JA (1984) The natural history of hepatic metastases from colorectal cancer. Ann Surg 199: 199–502CrossRefGoogle Scholar
  75. Welch TJ, Sheedy PF, Johnson CM (1985) Focal nodular hyperplasia and hepatic adenoma: comparision of angiography, CT, US and scintigraphy. Radiology 156: 593–595PubMedGoogle Scholar
  76. Wernecke K, Rummeney E, Bongartz G, Vassallo P, Kivelitz D, Wiesmann W, Peters PE, Reiser M, Pircher W (1991) Detection of hepatic masses in patients with carcinoma: comparative sensitivities of sonography, CT, and MR imaging. AJR 157: 731–739PubMedGoogle Scholar
  77. Wolf RF, Goodnight JE, Krag DE, Schneide PD (1991) Results of resection and proposed guidelines for patient selection in instances of non-colorectal hepatic metastases. Surg Gynecol Obstect 173: 454–460.Google Scholar
  78. Zukiwski A, Wallac S, Guterman J, Saks S, Mavligit G (1989) Hepatic arterial infusion of recombinant tumor necrosis factor in patients with metastatic carcinoma to the liver. Proc Am Soc Clin Oncol 8:122Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1996

Authors and Affiliations

  • P. M. Schlag
    • 1
  • M. Hünerbein
    • 1
  • P. Hohenberger
    • 1
  1. 1.Virchow Hospital, Robert Ròssle Hospital and Tumor InstituteHumboldt UniversityBerlinGermany

Personalised recommendations